Idiopathic pulmonary fibrosis and pirfenidone

被引：15

作者：

Collard, H. R. ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

来源：

EUROPEAN RESPIRATORY JOURNAL | 2010年 / 35卷 / 04期

关键词：

PLACEBO-CONTROLLED TRIAL; END-POINTS;

D O I：

10.1183/09031936.00006610

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：728 / 729

页数：2

共 14 条

[1] Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].

Collard, HR ;

King, TE ;

Bartelson, BB ;

Vourlekis, JS ;

Schwarz, MI ;

Brown, KK .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542

[2] High-dose acetylcysteine in idiopathic pulmonary fibrosis [J].

Demedts, M ;

Behr, J ;

Buhl, R ;

Costabel, U ;

Dekhuijzen, R ;

Jansen, HM ;

MacNee, W ;

Thomeer, M ;

Wallaert, B ;

Laurent, F ;

Nicholson, AG ;

Verbeken, EK ;

Verschakelen, J ;

Flower, CDR ;

Capron, F ;

Petruzzelli, S ;

De Vuyst, P ;

van den Bosch, JMM ;

Rodriguez-Becerra, E ;

Corvasce, G ;

Lankhorst, I ;

Sardina, M ;

Montanari, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2229-2242

[3]

*INTERMUNE, INV REL

[4] BUILD-1:: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis [J].

King, Talmadge E., Jr. ;

Behr, Juergen ;

Brown, Kevin K. ;

du Bois, Roland M. ;

Lancaster, Lisa ;

de Andrade, Joao A. ;

Staehler, Gerd ;

Leconte, Isabelle ;

Roux, Sebastien ;

Raghu, Ganesh .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (01) :75-81

[5] Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial [J].

King, Talmadge E., Jr. ;

Albera, Carlo ;

Bradford, Williamson Z. ;

Costabel, Ulrich ;

Hormel, Phil ;

Lancaster, Lisa ;

Noble, Paul W. ;

Sahn, Steven A. ;

Szwarcberg, Javier ;

Thomeer, Michiel ;

Valeyre, Dominique ;

du Bois, Roland M. .

LANCET, 2009, 374 (9685) :222-228

[6] Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis [J].

King, TE ;

Safrin, S ;

Starko, KM ;

Brown, KK ;

Noble, PW ;

Raghu, G ;

Schwartz, DA .

CHEST, 2005, 127 (01) :171-177

[7]

Liu Guanghan, 2002, J Biopharm Stat, V12, P207, DOI 10.1081/BIP-120015744

[8] Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance [J].

ONeill, RT .

CONTROLLED CLINICAL TRIALS, 1997, 18 (06) :550-556

[9] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis [J].

Raghu, G ;

Brown, KK ;

Bradford, WZ ;

Starko, K ;

Noble, PW ;

Schwartz, DA ;

King, TE ;

Adlakha, A ;

Tarczynski, S ;

Ainslie, G ;

Kalam, R ;

Bai, T ;

Truchan, H ;

Baughman, R ;

Wingst, D ;

Bhorade, S ;

Norwick, L ;

Brown, KK ;

Kervitsky, D ;

Calhoun, W ;

DiNella, L ;

Chan, C ;

Jamieson, L ;

Chan, K ;

Turpen, T ;

Chapman, J ;

Slattery, S ;

Chen, L ;

Turner, J ;

Clark, M ;

Sanders, R ;

Crain, M ;

Pate, D ;

Davis, G ;

Lynn, M ;

Dhar, A ;

Hrytsytk, M ;

Drent, M ;

Horr, ET ;

du Bois, R ;

Goh, N ;

Egan, J ;

Anthony, N ;

Enelow, R ;

Haram, T ;

Ettinger, N ;

Merli, S ;

Frost, A ;

Holy, R ;

Glassberg, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (02) :125-133

[10] Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone - Results of a prospective, open-label phase II study [J].

Raghu, G ;

Johnson, WC ;

Lockhart, D ;

Mageto, Y .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1061-1069

← 1 2 →